Preliminary Communication

Treatment of Critically Ill Patients With COVID-19 With Convalescent Plasma

Chenguang Shen, PhD; Zhaoqin Wang, PhD; Fang Zhao, PhD; Yang Yang, MD; Jinxiu Li, MD; Jing Yuan, MD; Fuxiang Wang, MD; Delin Li, PhD; Minghui Yang, PhD; Li Xing, MM; Jinli Wei, MM; Haixia Xiao, PhD; Yan Yang, MM; Jiuxin Qu, MD; Ling Qing, MM; Li Chen, MD; Zhixiang Xu, MM; Ling Peng, MM; Yanjie Li, MM; Haixia Zheng, MM; Feng Chen, MM; Kun Huang, MM; Yujing Jiang, MM; Dongjing Liu, MD; Zheng Zhang, MD; Yingxia Liu, MD; Lei Liu, MD
Medical News & Perspectives

Testing an Old Therapy Against a New Disease: Convalescent Plasma for COVID-19

Rita Rubin, MA
Original Investigation

Convalescent Plasma Therapy and Clinical Improvement in Severe and Life-threatening COVID-19

Ling Li, MD, PhD; Wei Zhang, MD; Yu Hu, MD, PhD; Xunliang Tong, MD, PhD; Shangen Zheng, MD; Juntao Yang, PhD; Yujie Kong, MD; Lili Ren, PhD; Qing Wei, MD; Heng Mei, MD, PhD; Caiying Hu, MD; Cuihua Tao, MD; Ru Yang, MD; Jue Wang, MD; Yongpei Yu, PhD; Yong Guo, PhD; Xiaoxiong Wu, MD; Zhihua Xu, MD; Li Zeng, MD; Nian Xiong, MD, PhD; Lifeng Chen, MD; Juan Wang, MD; Ning Man, MD; Yu Liu, PhD; Haixia Xu, MD; E. Deng, MS; Xuejun Zhang, MS; Chenyue Li, MD; Conghui Wang, PhD; Shisheng Su, PhD; Linqi Zhang, PhD; Jianwei Wang, PhD; Yanyun Wu, MD, PhD; Zhong Liu, MD, PhD
JAMA Patient Page

Patient Information: Caring for Someone With COVID-19

Lindsey Y. Mortenson, MD; Preeti N. Malani, MD, MSJ; Robert D. Ernst, MD
JAMA Patient Page

Patient Information: Caring for Someone With COVID-19

Lindsey Y. Mortenson, MD; Preeti N. Malani, MD, MSJ; Robert D. Ernst, MD
Original Investigation

Association of Convalescent Plasma Treatment With Clinical Outcomes in Patients With COVID-19

Perrine Janiaud, PhD; Cathrine Axfors, MD, PhD; Andreas M. Schmitt, MD; Viktoria Gloy, PhD; Fahim Ebrahimi, MD, MSc; Matthias Hepprich, MD; Emily R. Smith, ScD, MPH; Noah A. Haber, ScD; Nina Khanna, MD; David Moher, PhD; Steven N. Goodman, MD, PhD; John P. A. Ioannidis, MD, DSc; Lars G. Hemkens, MD, MPH

Read Article Claim CME

Donated convalescent plasma may be beneficial to patients with severe coronavirus disease 2019 (COVID-19) to boost their ability to fight the virus.

Most people who recover from COVID-19 develop antibodies (proteins that the immune system produces in response to infection) to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Antibodies are found in plasma, the yellow liquid portion of blood. Plasma is collected from donors who have recovered from COVID-19 through a process called apheresis, which uses a special machine to separate the blood into different components. The plasma is removed, while the rest of the blood components are returned into the donor’s body.

Claim CME

Buy This Activity

Article Information

Published Online: June 12, 2020. doi:10.1001/jama.2020.10699

Conflict of Interest Disclosures: None reported.

Sources: Fung MK, Eder A, Spitalnik SL, Westhoff CM, eds. Technical Manual. 19th ed. AABB Press; 2017.

US Food and Drug Administration. Recommendations for investigational COVID-19 convalescent plasma. www.fda.gov/vaccines-blood-biologics/investigational-new-drug-ind-or-device-exemption-ide-process-cber/recommendations-investigational-covid-19-convalescent-plasma

Convalescent Plasma and COVID-19

Convalescent Plasma to Treat COVID-19

Treatment of Critically Ill Patients With COVID-19 With Convalescent Plasma

Testing an Old Therapy Against a New Disease: Convalescent Plasma for COVID-19

Hopeful Signals From a Randomized Trial of Convalescent Plasma to Treat COVID-19

Convalescent Plasma Therapy and Clinical Improvement in Severe and Life-threatening COVID-19

Patient Information: Caring for Someone With COVID-19

Patient Information: Caring for Someone With COVID-19

Association of Convalescent Plasma Treatment With Clinical Outcomes in Patients With COVID-19

See More

Convalescent Plasma and COVID-19

Convalescent Plasma to Treat COVID-19

Treatment of Critically Ill Patients With COVID-19 With Convalescent Plasma

Testing an Old Therapy Against a New Disease: Convalescent Plasma for COVID-19

Hopeful Signals From a Randomized Trial of Convalescent Plasma to Treat COVID-19

Convalescent Plasma Therapy and Clinical Improvement in Severe and Life-threatening COVID-19

Patient Information: Caring for Someone With COVID-19

Patient Information: Caring for Someone With COVID-19

Association of Convalescent Plasma Treatment With Clinical Outcomes in Patients With COVID-19

See More

See More About

If you are not a JN Learning subscriber, you can either:

A subscription to JN Learning (CME from JAMA Network) provides:

Sign in to access

If you are not a JN Learning subscriber, you can either:

Sign in to customize your interests

With a personal account, you can:

Name Your Search

Sign in to save your search

With a personal account, you can:

Lookup An Activity

My Saved Searches

Sign in to customize your interests

With a personal account, you can:

Purchase access